- Home
- MDXG vs RERE Comparison
MDXG vs RERE Comparison
Compare MDXG & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- RERE
- Stock Information
- Founded
- MDXG 2006
- RERE 2011
- Country
- MDXG United States
- RERE China
- Employees
- MDXG N/A
- RERE N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- RERE Other Specialty Stores
- Sector
- MDXG Health Care
- RERE Consumer Discretionary
- Exchange
- MDXG Nasdaq
- RERE Nasdaq
- Market Cap
- MDXG 877.4M
- RERE 757.2M
- IPO Year
- MDXG N/A
- RERE 2021
- Fundamental
- Price
- MDXG $7.02
- RERE $3.60
- Analyst Decision
- MDXG Strong Buy
- RERE
- Analyst Count
- MDXG 2
- RERE 0
- Target Price
- MDXG $12.00
- RERE N/A
- AVG Volume (30 Days)
- MDXG 1.0M
- RERE 2.5M
- Earning Date
- MDXG 07-30-2025
- RERE 08-20-2025
- Dividend Yield
- MDXG N/A
- RERE N/A
- EPS Growth
- MDXG N/A
- RERE N/A
- EPS
- MDXG 0.21
- RERE 0.07
- Revenue
- MDXG $363,774,000.00
- RERE $2,388,301,386.00
- Revenue This Year
- MDXG $9.55
- RERE $27.37
- Revenue Next Year
- MDXG $11.43
- RERE $24.06
- P/E Ratio
- MDXG $33.21
- RERE $48.17
- Revenue Growth
- MDXG 6.85
- RERE 26.09
- 52 Week Low
- MDXG $5.47
- RERE $2.00
- 52 Week High
- MDXG $10.14
- RERE $4.35
- Technical
- Relative Strength Index (RSI)
- MDXG 55.25
- RERE 58.46
- Support Level
- MDXG $6.91
- RERE $3.07
- Resistance Level
- MDXG $7.37
- RERE $3.67
- Average True Range (ATR)
- MDXG 0.33
- RERE 0.15
- MACD
- MDXG 0.02
- RERE -0.00
- Stochastic Oscillator
- MDXG 36.18
- RERE 87.79
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.